Previous 10 | Next 10 |
Calls on Board to Stop Wasting Corporate Resources and Hold a Stockholder Vote as Soon as Possible Questions the Board’s Apparent Desire to Keep Stockholders in the Dark on Key Details Bradley L. Radoff and Michael Torok (together with their affiliates, the “...
NEW YORK, NY / ACCESSWIRE / January 5, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Trean Insurance Group, Inc. (NASDAQ:TI...
Amid opposition from some shareholders, the board of directors of Sesen Bio ( NASDAQ: SESN ) has reiterated support for its planned merger with Carisma Therapeutics saying it is the best move for shareholders. The company said that after a comprehensive review of strategic alterna...
Highlights Expected Special Cash Dividend of Approximately $70 Million, and Upside of CVR and Ownership of Combined Company Sesen Bio, Inc. (Nasdaq: SESN) today issued the following statement reiterating the Company’s confidence in, and commitment to, the pending merger with Cari...
Sesen Bio ( NASDAQ: SESN ) investors reiterated their plan to vote against the merger with Carisma Therapuetics, calling it a an "illogical, value-destructive" deal. Sesen rose 4.2%. Bradley L. Radoff and Michael Torok, along with their affiliates, who own appr...
Proposes Alternative to the Merger That Would Deliver Superior Value for Sesen Bio’s Stockholders Questions the Sesen Bio Board’s Resistance to Obtaining a New Fairness Opinion for Carisma Now That Comparable Companies Have Declined 30%-60% Since the Merger Announcement ...
Summary I explain why I've added Organigram to my tax loss selling basket. I also review the company's performance and risks. Finally, I recap my entire 2022 tax loss selling basket of stocks, some of which I didn't have time to write up individually. Tax Loss Selling Strategy...
Sesen Bio ( NASDAQ: SESN ) stock climbed 35.4% after the bell on Thursday after the firm said it will increase the one-time special cash dividend to its shareholders to ~$70M, or ~$0.34/share. The special dividend, in connection with Sesen's ( SESN ) acquisition by Caris...
Sesen Bio Stockholders Expected to Receive Approximately $70 Million Special Cash Dividend, an Increase from up to $25 Million Previously Announced Contingent Value Right to Include Proceeds of Vicineum and Other Preclinical Assets, in Addition to Previously Announced Proceeds of ...
Are Penny Stocks A Buy Under $1 Or Too Risky? The penny stock definition generally refers to stocks under $5. But if you’re an active trader, you know that isn’t the whole story. If you take out all other variables and leave the price as the only one, the cheaper the stock...
News, Short Squeeze, Breakout and More Instantly...
Sesen Bio Inc. Company Name:
SESN Stock Symbol:
NASDAQ Market:
Declares Special Dividend in the Aggregate of $75 Million Approximately 88% Voted in Favor of the Merger at the Special Meeting Merger on Track to Close on March 7, 2023 Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today anno...
Sesen Bio Board Believes the Pending Merger with Carisma is the Most Value-Maximizing Option for Stockholders Reiterates Support from Several of Sesen Bio’s Largest Stockholders and Two Leading Independent Proxy Advisors Sesen Bio Board Unanimously Recommends All St...
Positive Recommendations Underscore that Carisma Merger Maximizes Value for Sesen Bio Stockholders Sesen Bio Board Unanimously Recommends All Stockholders to Follow ISS and Glass Lewis’s Recommendations to Vote “FOR” Value Maximizing Merger on WHITE ...